Preapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemia

Blood

Volumn 121, Issue 21, 2013, Pages 4340-4347

  Ishihara, Makoto ^a   Araya, Natsumi ^b   Sato, Tomoo ^b   Tatsuguchi, Ayako ^a   Saichi, Naomi ^a   Utsunomiya, Atae ^c   Nakamura, Yusuke ^d   Nakagawa, Hidewaki ^a   Yamano, Yoshihisa ^b   Ueda, Koji ^a  

^a RIKEN   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c IMAMURA BUN IN HOSPITAL   (Japan)

^d SECTION OF HEMATOLOGY ONCOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 2; CALPHOBINDIN II; CD6 ANTIGEN; CELL ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR4; CXCL7 CHEMOKINE; EARLY PREGNANCY FACTOR; EOSINOPHIL LYSOPHOSPHOLIPASE; FODRIN; GLYCINE HYDROXYMETHYLTRANSFERASE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 71; HLA DRB1 ANTIGEN; LIPOCORTIN 1; LYSOPHOSPHOLIPASE; MOESIN; MYELOID CELL NUCLEAR DIFFERENTIATION ANTIGEN; PARATHYMOSIN; PRG2 PROTEIN; PROTEIN; PROTEOGLYCAN; STAT1 PROTEIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CALPAIN; CAPN2 PROTEIN, HUMAN; SMALL INTERFERING RNA; SPECTRIN;

ADULT; APOPTOSIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REPRESSION; FLOW CYTOMETRY; GENE OVEREXPRESSION; HTLV-1 INFECTION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEOMICS; SUPPORT VECTOR MACHINE; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION; TROPICAL SPASTIC PARAPARESIS; UPREGULATION; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL LINE; CELL SURVIVAL; CYTOLOGY; DISEASE COURSE; GENETICS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; VIROLOGY;

ADULT; APOPTOSIS; BIOLOGICAL MARKERS; CALPAIN; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL LINE; CELL SURVIVAL; DISEASE PROGRESSION; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PROTEOMICS; RNA, SMALL INTERFERING; SPECTRIN;

MLCS; MLOWN;

EID: 84880408198     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-08-446922     Document Type: Article

References (29)

1. Yamashita M, Ido E, Miura T, Hayami M. Molecular epidemiology of HTLV-I in the world. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1):S124-S131.
2. Asquith B, Zhang Y, Mosley AJ, et al. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc Natl Acad Sci U S A. 2007;104(19):8035-8040.
3. Sakashita A, Hattori T, Miller CW, et al. Mutations of the p53 gene in adult T-cell leukemia. Blood. 1992;79(2):477-480.
4. Beltran B, Quiñones P, Morales D, Cotrina E, Castillo JJ. Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/ lymphoma. Leuk Res. 2011;35(3):334-339.
5. Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012; 30(8):837-842.
6. Semmes OJ, Cazares LH, Ward MD, et al. Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease. Leukemia. 2005;19(7):1229-1238.
7. Kirk PD, Witkover A, Courtney A, et al. Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis. Retrovirology. 2011;8:81.
8. Rahman S, Quann K, Pandya D, Singh S, Khan ZK, Jain P. HTLV-1 Tax mediated downregulation of miRNAs associated with chromatin remodeling factors in T cells with stably integrated viral promoter. PLoS ONE. 2012;7(4):e34490.
9. Polakowski N, Gregory H, Mesnard JM, Lemasson I. Expression of a protein involved in bone resorption, Dkk1, is activated by HTLV-1 bZIP factor through its activation domain. Retrovirology. 2010;7:61.
10. Yamano Y, Araya N, Sato T, et al. Abnormally high levels of virus-infected IFN-gamma1 CCR41 CD41 CD251 T cells in a retrovirus-associated neuroinflammatory disorder. PLoS ONE. 2009;4(8):e6517.
11. Oh JH, Gao J, Nandi A, Gurnani P, Knowles L, Schorge J. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling. Genome Inform. 2005;16(2):195-204.
12. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1(11): 845-867.
13. Nordon IM, Brar R, Hinchliffe RJ, Cockerill G, Thompson MM. Proteomics and pitfalls in the search for potential biomarkers of abdominal aortic aneurysms. Vascular. 2010;18(5):264-268.
14. Ueda K, Katagiri T, Shimada T, et al. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer. J Proteome Res. 2007;6(9): 3475-3483.
15. Ueda K, Fukase Y, Katagiri T, et al. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays. Proteomics. 2009;9(8):2182-2192.
16. Ueda K, Takami S, Saichi N, et al. Development of serum glycoproteomic profiling technique; simultaneous identification of glycosylation sites and site-specific quantification of glycan structure changes. Mol Cell Proteomics. 2010;9(9): 1819-1828.
17. Ueda K, Saichi N, Takami S, et al. A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma. PLoS ONE. 2011;6(4): e18567.
18. Bahbouhi B, al-Harthi L. Enriching for HIV-infected cells using anti-gp41 antibodies indirectly conjugated to magnetic microbeads. Biotechniques. 2004;36(1): 139-147.
19. Matsubar Y, Hori T, Morita R, Sakaguchi S, Uchiyama T. Delineation of immunoregulatory properties of adult T-cell leukemia cells. Int J Hematol. 2006;84(1):63-69.
20. Best I, López G, Verdonck K, et al. IFN-gamma production in response to Tax 161-233, and frequency of CD41 Foxp31 and Lin HLA-DRhigh CD1231 cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population. Immunology. 2009; 128(1, pt 2):e777-e786.
21. Nakamura N, Fujii M, Tsukahara T, et al. Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells. Oncogene. 1999;18(17): 2667-2675.
22. Alaiya AA, Al-Mohanna M, Aslam M, et al. Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma. Int J Oncol. 2011;38(4): 1047-1057.
23. Cappello F, Rappa F, David S, Anzalone R, Zummo G. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis. Anticancer Res. 2003;23(2B): 1325-1331.
24. Letsas KP, Vartholomatos G, Tsepi C, Tsatsoulis A, Frangou-Lazaridis M. Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin alpha and parathymosin in thyroid: novel proliferation markers? Neoplasma. 2007; 54(1):57-62.
25. Anderson DD, Quintero CM, Stover PJ. Identification of a de novo thymidylate biosynthesis pathway in mammalian mitochondria. Proc Natl Acad Sci USA. 2011;108(37): 15163-15168.
26. Storr SJ, Carragher NO, Frame MC, Parr T, Martin SG. The calpain system and cancer. Nat Rev Cancer. 2011;11(5):364-374.
27. Liu MC, Akle V, Zheng W, et al. Comparing calpain- and caspase-3-mediated degradation patterns in traumatic brain injury by differential proteome analysis. Biochem J. 2006;394(pt 3): 715-725.
28. Wallis CJ, Wenegieme EF, Babitch JA. Characterization of calcium binding to brain spectrin. J Biol Chem. 1992;267(7): 4333-4337.
29. Liu X, Van Vleet T, Schnellmann RG. The role of calpain in oncotic cell death. Annu Rev Pharmacol Toxicol. 2004;44: 349-370.